Key result
PMM-034 inhibits enterovirus 71 replication with an IC50 of ~2.3 μg/mL and suppresses inflammation.
Why the study?
Does PMM-034 inhibit EV71 replication and reduce pro-inflammatory cytokine expression in EV71-infected RD cells?
Does PMM-034 inhibit EV71 replication and reduce pro-inflammatory cytokine expression in EV71-infected RD cells?
PMM-034 demonstrates potent in vitro antiviral and anti-inflammatory activity against enterovirus 71, suggesting its potential as a candidate for hand, foot, and mouth disease treatment.
PMM-034 merits further preclinical evaluation against EV71; leaves open translation to in vivo models or clinical HFMD.
Human enterovirus 71 (EV71) is the major causative agent of hand, foot, and mouth disease (HFMD), particularly in infants and children below 4 years of age. Shikonin is a bioactive compound with anti-inflammatory, antiviral, and antibacterial activities derived from the roots of the Chinese medicinal herb Lithospermum erythrorhizon. This study aimed to examine the antiviral activity of PMM-034, a shikonin ester derivative, against EV71 in rhabdomyosarcoma (RD) cells. Cytotoxicity of PMM-034 on RD cells was determined using WST-1 assay. Dose- and time-dependent effects of PMM-034 on EV71 replication in RD cells were determined using plaque reduction assay. mRNA expression levels of EV71/VP1 and pro-inflammatory cytokines (IL-1β, IL-6, IL-8, and TNF-α) were determined by real-time RT-PCR, and EV71/VP1 and phospho-p65 protein expressions were determined by western blot analysis. PMM-034 exhibited only weak cytotoxicity against RD cells. However, PMM-034 exhibited significant antiviral activity against EV71 in RD cells with 50% inhibitory concentration of 2.31 μg/mL. The VP1 mRNA and protein levels were significantly reduced in cells treated with PMM-034. Furthermore, relative mRNA expression levels of IL-1β, IL-6, IL-8, and TNF-α significantly decreased in the cells treated with PMM-034, while the phospho-p65 protein expression was also significantly lower in the treated cells. These results indicated that PMM-034 suppressed the expressions of pro-inflammatory cytokines in RD cells, exhibiting antiviral activity against EV71, as evidenced by the reduced VP1 mRNA and protein levels in PMM-034-treated cells. Thus, PMM-034 is a promising candidate for further development as an EV71 inhibitor.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2017) studied Enterovirus 71 infection. PMM-034 vs. DMSO (vehicle control) was evaluated on 50% inhibitory concentration (IC50) for EV71 replication. PMM-034 exhibited significant antiviral activity against enterovirus 71 in rhabdomyosarcoma cells with a 50% inhibitory concentration of 2.31 μg/mL, while also suppressing pro-inflammatory cytokine expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: